asco highlights: bevacizumab for relapsed ovarian cancer
Published 6 years ago • 111 plays • Length 3:35Download video MP4
Download video MP3
Similar videos
-
2:19
asco highlights: keynote100
-
7:32
bevacizumab for recurrent ovarian cancer
-
47:21
asco 2023: highlights and analysis
-
6:04
when to add bevacizumab for recurrent ovarian cancer
-
4:54
bevacizumab in recurrent ovarian cancer
-
2:51
gynaecology highlights from asco 2018
-
3:21
asco: targeted agent slows recurrent ovarian cancer
-
6:10
ago-ovar 2.29/engot-ov34: atezolizumab vs placebo bevacizumab w/ chemo recurrent ovarian cancer
-
3:39
asco 2013: delayed relapse of advanced ovarian cancer when treating with pazopanib
-
28:03
highlights from asco 2021
-
10:55
the efficacy of bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian c...
-
31:36
icaho20 - asco direct™ highlights - gynecological oncology session - dr. elise simons
-
5:41
bevacizumab’s role in recurrent ovarian cancer
-
4:40
asco 2023 highlights on the mirasol trial in pt-resistant adv. high-grade epithelial ovarian cancer
-
6:34
bevacizumab’s value in recurrent ovarian cancer
-
6:36
atezolizumab versus placebo in combination with bevacizumab and non-platinum-based chemotherapy ...
-
4:23
comment: parp inhibitor olaparib plus bevacizumab in women with ovarian cancer
-
1:00
rationalizing use of pembrolizumab/bevacizumab in recurrent ovarian cancer
-
0:52
dr. mirza on safety profile of niraparib/bevacizumab in recurrent ovarian cancer